Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UK orders health service to be ready for vaccine by December

Published 10/11/2020, 07:23
Updated 10/11/2020, 07:45
© Reuters. British Health Secretary Matt Hancock speaks about the coronavirus disease (COVID-19) in the House of Commons Chamber, in London

LONDON (Reuters) - The British government has asked the National Health Service to be ready to deploy any COVID vaccine from the start of December and it will then roll it out, starting with the most vulnerable, the health minister said on Tuesday.

Matt Hancock told Sky News that there were many hurdles still to clear and the government would not deploy the shot until it was confident in its clinical safety.

News on Monday that a vaccine from Pfizer (NYSE:PFE) and BioNTech was more than 90% effective sparked a surge in financial markets around the world, a rare piece of good news in the fight against a disease that has killed more than a million people.

Britain expects to have 10 million doses of the vaccine available by the end of the year.

"I've asked them (the NHS) to be ready from the start of December," he said.

"Of course there are many hurdles that need to be gone over and we haven't seen the full safety data and obviously that is critical and we won't deploy a vaccine unless we can be confident in its clinical safety."

He added that he did not know when there would be an update on the trial results of a vaccine being produced by Oxford University and AstraZeneca.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.